专利号:US-8093381-B2 优先权日:2007-05-24 标题:Method of synthesis of fluoroquinolones 发明人:BERTHON-CEDILLE LAURENCE; LEGUERN MARIE-EMMANUELLE; RENAUD GILLES; TOMBRET FRANCIS 权利人:BERTHON-CEDILLE LAURENCE; LEGUERN MARIE-EMMANUELLE; RENAUD GILLES; TOMBRET FRANCIS; BIOCODEX 摘要:The invention relates to a method of preparation of fluoroquinolones of formula (I) from compounds of formula (II): n nin which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and X are as defined in Claim 1.
专利号:US-2010203587-A1 优先权日:2009-01-13 标 题:Use of dna gyrase inhibitors for in vitro polypeptide synthesis reactions 发明人:VOLOSHIN ALEXEI M; ZAWADA JAMES F; GOLD DANIEL 权利人:SUTRO BIOPHARMA INC 摘要:The present invention provides methods and compositions useful for in vitro polypeptide synthesis reactions. The methods involve the use of DNA gyrase inhibitors to prevent bacterial contamination in lysates used for in vitro production of polypeptides. The compositions include contamination-free cell lysates for in vitro protein synthesis reactions.
专利号:US-2024207302-A1 优先权日:2021-04-01 标 题 :Antiviral compounds, methods for the manufacturing of compounds, antiviral pharmaceutical composition, use of the compounds and method for the oral treatment of coronavirus infection and related diseases thereof 发明人:CALIXTO JOãO BATISTA; RABI NALLAR JAIME ALBERTO; LOPES E SOUZA THIAGO MORENO 权利人:CALIXTO JOAO BATISTA; RABI NALLAR JAIME ALBERTO; LOPES E SOUZA THIAGO MORENO 摘要:The present invention relates to antiviral compounds selected from cytokinins, their nucleosides and nucleotide analogs, and their prodrugs as inhibitors of viral RNA synthesis, or their salts, solvates, derivatives, or even combinations of aforementioned compounds, for prophylactic treatment, curative (therapeutic) or mitigative coronavirus infection, represented by human and veterinary coronavirus, SARS-COV-2 and MHIV, and for the treatment of individuals potentially exposed to COVID-19. The present invention also comprises the methods for the manufacturing of such compounds, the antiviral pharmaceutical composition containing the compounds of the invention, as well as the use of the compounds, combinations of compounds, and method for the prophylactic, curative (therapeutic) or mitigative treatment of coronavirus infection, represented by coronavirus, in especial SARS-COV-2 and of patients with COVID-19, individual infected with SARS-COV-2 or potentially exposed to this virus. The antiviral activity of the compounds of this invention against SARS-COV-2 was greatly enhanced by inhibiting the 3′-5′-exonuclease. Synergistic results of the compounds according to the present invention were obtained from the combination with repurposed drugs.
专利号:US-7632944-B2 优先权日:2007-01-24 标题 :Quinolone carboxylic acids, derivatives thereof, and methods of making and using same 发明人:HARMS ARTHUR E 权利人:BAUSCH & LOMB 摘要:A process of preparing a quinolone carboxylic acid or its derivatives having Formula I, Ia, or IV, as shown herein, comprises using a starting quinolone that already has one or more desired substituents at one or more particular positions on the quinolone ring and preserving the orientation of such substituents throughout the synthesis. The present process comprises fewer steps than prior-art processes. The present process also can include a simple separation of a desired enantiomer of the quinolone carboxylic acid or its derivatives from the enantiomeric mixture. Pharmaceutical compositions comprising fluoroquinolones prepared by the present process can be used effectively against a variety of microbial pathogens.
专利号:US-8227597-B2 优先权日:2006-10-06 标题 :Quinolone carboxylic acids, derivatives thereof, and methods of making and using same 发明人:HARMS ARTHUR E 权利人:HARMS ARTHUR E; BAUSCH & LOMB 摘要:A process of preparing a quinolone carboxylic acid or its derivatives having Formula I, Ia, or IV, as shown herein, comprises using a starting quinolone that already has one or more desired substituents at one or more particular positions on the quinolone ring and preserving the orientation of such substituents throughout the synthesis. The present process comprises fewer steps than prior-art processes. The present process also can include a simple separation of a desired enantiomer of the quinolone carboxylic acid or its derivatives from the enantiomeric mixture. Pharmaceutical compositions comprising fluoroquinolones prepared by the present process can be used effectively against a variety of microbial pathogens.
专利号:US-2009054643-A1 优先权日:2007-05-24 标 题:Novel method of synthesis of fluoroquinolones
1: Narayanan V, Motlekar S, Kadhe G, Bhagat S. Efficacy and safety of nadifloxacin for bacterial skin infections: results from clinical and post-marketing studies. Dermatol Ther (Heidelb). 2014 Dec;4(2):233-48. doi: 10.1007/s13555-014-0062-1. Epub 2014 Sep 12. 2: Jung JY, Kwon HH, Yeom KB, Yoon MY, Suh DH. Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients. Int J Dermatol. 2011 Mar;50(3):350-7. doi: 10.1111/j.1365-4632.2010.04701.x. doi: 10.4103/0250-474X.106066. 4: Takigawa M, Tokura Y, Shimada S, Furukawa F, Noguchi N, Ito T; Acne Study Group. Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris. J Dermatol. 2013 Aug;40(8):620-5. doi: 10.1111/1346-8138.12189. Epub 2013 Jun 3. doi: 10.1111/j.1346-8138.2011.01280.x. Epub 2011 Oct 18. doi: 10.1111/j.1365-2230.2011.04214.x. Epub 2011 Nov 21. doi: 10.4103/0019-5154.135492.
合成参考文献
参考文献:10.2165/11587280-000000000-00000 摘要:Tomé AM, Filipe A. Quinolones: review of psychiatric and neurological adverse reactions. Drug Saf. 2011 Jun 01;34(6):465–88. doi: 10.2165/11587280-000000000-00000. 参考文献:10.1007/s10928-017-9506-4 摘要:Bush K, Page MGP. What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles. Journal of Pharmacokinetics and Pharmacodynamics. 2017 Feb 04;44(2):113–32. doi: 10.1007/s10928-017-9506-4. 参考文献:10.3390/molecules27051504 摘要:Hutchins M, Bovill RA, Stephens PJ, Brazier JA, Osborn HMI. Glycosides of Nadifloxacin-Synthesis and Antibacterial Activities against Methicillin-Resistant Staphylococcus aureus. Molecules. 2022 Feb 23;27(5). 参考文献:10.2165/00003495-199958002-00001 摘要:Andriole VT. The future of the quinolones. Drugs. 1999;58 Suppl 2():1–5. doi: 10.2165/00003495-199958002-00001.